GAD THOMAS (President and Chairman) sold 33.2% of their position (281.17K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.02M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/9/2022ACC: 0001104659-22-017278
DirectorOfficer· President and Chairman
Since Sep 2018
-281.17K
Net shares
Net seller
$2.02M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
281.17K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−91.03K
Price / share
$7.59
Trade value
$691.18K
% of position
10.8%
2/7/2022
846.20K→755.17K
Common Stock
Indirect
Shares
−125.86K
Price / share
$7.01
Trade value
$882.89K
% of position
16.7%
2/8/2022
755.17K→629.31K
Common Stock
Indirect
Shares
−64.28K
Price / share
$6.96
Trade value
$447.12K
% of position
10.2%
2/9/2022
629.31K→565.03K
Total
Net shares
−281.17K
Net value
-$2.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/7/2022 | S · Sale | −91.03K | $7.59 | $691.18K | 10.8% | 846.20K | 755.17K |
| Common Stock Indirect | 2/8/2022 | S · Sale | −125.86K | $7.01 | $882.89K | 16.7% | 755.17K | 629.31K |
| Common Stock Indirect | 2/9/2022 | S · Sale | −64.28K | $6.96 | $447.12K | 10.2% | 629.31K | 565.03K |
| Total | −281.17K | -$2.02M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned50K
Common Stock
IndirectShares owned60K
Total
50K direct·60K indirect110K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 50K | Direct |
| Common Stock | 60K | Indirect |
| Total | 110K | 50K direct·60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported